Managed Health Care

Alignment Healthcare

Alignment Healthcare EVP Joseph S. Konowiecki Sells 25,000 Shares for $525,000

Alignment Healthcare CEO John E. Kao Sells 298,000 Shares

Alignment Healthcare to Speak at Goldman Sachs 47th Global Healthcare Conference

Alignment Health Plan Recognized by PQA as One of Four Top Medicare Advantage Prescription Drug Plans for 2026

Alignment Healthcare CEO John E. Kao Sells Shares

Alignment Healthcare Optimistic About Second Quarter Prospects

Alignment Healthcare released FY2026 Q1 earnings on April 30 After-Market EST, actual revenue USD 1.235 B (forecast USD 1.218 B), actual EPS USD 0.05 (forecast USD 0.0083)

Alignment Healthcare's Q1 Net Profit Surpasses Expectations

Alignment Healthcare to Release FY2026 Q1 Earnings on April 30 After-Market EST, Forecast Revenue USD 1.218 B, EPS USD 0.0083

Alignment Healthcare CEO sold 118,000 common stocks

Alignment Healthcare stock price falls after hours, General Atlantic plans to sell off shares

Alignment Healthcare released FY2025 earnings on February 26 After-Market EST, actual revenue USD 3.949 B (forecast USD 3.941 B), actual EPS USD -0.0036 (forecast USD -0.1037)

Alignment Healthcare released FY2025 Q4 earnings on February 26 After-Market EST, actual revenue USD 1.013 B (forecast USD 1.003 B), actual EPS USD -0.0554 (forecast USD -0.1521)

Alignment Healthcare to Release FY2025 Q4 Earnings on February 26, 2026 After-Market EST, Forecast Revenue USD 1.003 B, EPS USD -0.1521

Alignment Healthcare CEO Dawn Sells Shares

Alignment Healthcare Inc. Reaffirms 2025 Guidance and Outlines 2026 Projections

Alignment Healthcare's CEO sells company stocks

Analysts Upgrade Alignment Healthcare's Stock Rating, Target Price Increased

Alignment Healthcare insiders sell large number of stocks

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

ALHC

ELOX

RNAC

RGNT

Top biotech gainers on Tuesday included Regentis (RGNT), up 88% on knee repair implant updates; Eloxx (ELOX), soaring 77% after Nasdaq uplisting and public offering; Alignment Healthcare (ALHC), rising 25% on executive RSU grants and revenue guidance; and Cartesian Therapeutics (RNAC), gaining 16% via a strategic CAR-T licensing deal with WestGene.

rttnews

Eloxx Pharmaceuticals

Cartesian Therapeutics

Regentis Biomaterials

Larimar Therapeutics

Top Biotech Gainers: RGNT Walks The Talk, ELOX Returns To Relevance, ALHC Rallies, LRMR On Watch

NUVL

PAYO

VELO

CECO

ZVRA

FCEL

DKNG

VRRM

Nuvalent(NUVL) rose 39.28%, with a trading turnover 6.4 Billion USD, and a year-to-date rose 22.5%. Alignment Healthcare(ALHC) rose 25.08%, with a trading turnover 299.3 Million USD, and a year-to-date fell 2.8%. Payoneer Global(PAYO) rose 24.32%, with a trading turnover 331.1 Million USD, and a year-to-date rose 13.7%.

Top Gainers&Losers

Nuvalent

Payoneer Global

Velo3D

CECO Environmental

Zevra Therapeutics

FuelCell Energy

Draftkings

JM Smucker

Verra Mobility

Top 10 US Stock Gainers (6.9)

During Tuesday's intraday session, several healthcare stocks experienced significant volatility. ELOXX Pharma surged 2364.9% to $9.12, while Regentis Biomaterials rose 128.9%. Other gainers included Nuvalent, Rafael Holdings, Cartesian Therapeutics, and Alignment Healthcare. Conversely, Aditxt plummeted 43.3%, with iTonic Holdings, AIM ImmunoTech, Bio Green Med Solution, HCW Biologics, and Icecure Medical also posting notable declines.

benzinga_article

Rafael-B

Bio Green Med Solution

AIM ImmunoTech

Aditxt

Icecure Medical

HCW Biologics

iTonic

12 Health Care Stocks Moving In Tuesday's Intraday Session

Alignment Healthcare CEO John E. Kao sold 298,000 shares via a pre-arranged 10b5-1 plan for ~$5.03 million on May 11, 2026. While insider selling often raises concerns, this transaction reflects portfolio management rather than a lack of confidence, as Kao retains over 3.2 million shares. The article argues that policy risks in the Medicare Advantage sector, specifically CMS rate-setting and medical cost ratios, pose greater threats to investors than insider trading activity.

nasdaq

Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders

Analysts show bullish momentum for Zscaler and Alignment Healthcare. Zscaler has a consensus target of $195.07, suggesting 25% upside with rising earnings estimates. Alignment Healthcare signals a rebound as its RSI hits oversold levels at 22.76, while analysts raised EPS estimates by 14.6%. These moves occur within a market context where tech and healthcare sectors are active amidst narrow leadership in AI and semiconductors.

Zscaler

Zscaler and Alignment Healthcare see bullish analyst momentum

RKLB

LUNR

BKSY

JBIO

WOLF

Oculis Holding AG(OCS) fell 36.09%, with a trading turnover 98.9 Million USD, and a year-to-date fell 27.3%. Redwire(RDW) fell 15.83%, with a trading turnover 1.2 Billion USD, and a year-to-date rose 172.1%. Nuvalent(NUVL) fell 15.74%, with a trading turnover 289.4 Million USD, and a year-to-date fell 7.5%.

Oculis Holding AG

Redwire

Rocket Lab

Intuitive Machines

BlackSky Tech

Jade Biosciences

Sable Offshore

Wolfspeed

Top 10 US Stock Losers (6.1)

Alignment Healthcare (NASDAQ:ALHC) shares dropped 7.5% to $14.1650 on Monday, with trading volume down 41% from average. Despite the decline, Wall Street analysts maintain a 'Moderate Buy' consensus with an average price target of $24.30. Recent reports include JPMorgan raising its target to $26 and Barclays lowering it to $16. The company recently reported Q1 earnings beating estimates, with revenue up 33.3% year-over-year. Insider selling occurred in March and April, while some institutional investors increased their holdings.

Market Beat

JPMorgan Chase

Barclays

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Alignment Healthcare (NASDAQ:ALHC) Trading Down 7.5%  - Here's Why

Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity

Barchart Option

SPDR S&P Health

iShares US Healthcare Providers

Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity

Alignment Healthcare (NASDAQ:ALHC) remains optimistic about its Q2 outlook, citing stable medical costs and growth opportunities outside California. Executives reported improvements in medical benefit ratios and adjusted EBITDA, with 80% year-over-year growth. They emphasized strong data visibility and a care-centric model, which positions them favorably against competitors. Expansion into new markets is expected to enhance margins, despite higher medical loss ratios initially. The company is also monitoring potential changes in Medicare Advantage risk models and their implications for future growth.

Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes

John Kao, the Founder and CEO of the company, has taken on the additional responsibility of becoming the Chairman of the Board. This means that Kao will now be overseeing both the executive and board functions of the company. Under his leadership, the company has seen significant growth over the past few years, with revenue increasing by 25% and the number of employees doubling to over 500. Kao's dual role is expected to further streamline decision-making processes and drive continued success for the company.

Unusual Whales

Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation

Alignment Healthcare(ALHC.US)

Top Biotech Gainers: RGNT Walks The Talk, ELOX Returns To Relevance, ALHC Rallies, LRMR On Watch

Top 10 US Stock Gainers (6.9)

12 Health Care Stocks Moving In Tuesday's Intraday Session

Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders

Zscaler and Alignment Healthcare see bullish analyst momentum

Top 10 US Stock Losers (6.1)

Alignment Healthcare (NASDAQ:ALHC) Trading Down 7.5% - Here's Why

Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity

Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes

Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation